SAMM50 and neoplasm: The researchers developed three multipath CNN-based models: one to preoperatively predict pathologic complete response (pCR) to neoadjuvant chemoradiotherapy, one to assess tumor regression grade (TRG) (TRG0 and TRG1 vs. TRG2 and TRG3), and one to predict T downstaging.